AAAAAA

   
Results: 1-25 | 26-34
Results: 1-25/34
WEEKLY HIGH-DOSE 5-FLURORURACIL FOLINIC ACID (HD-5-FU/FA) IN CYTOSTATIC NAIVE OR PRETREATED ADVANCED COLORECTAL-CANCER - REMISSION RATES AND SURVIVAL/
Authors: GAULER TC ENGELS B RINAS U HELDER A NIEDERLE N
Citation: Tc. Gauler et al., WEEKLY HIGH-DOSE 5-FLURORURACIL FOLINIC ACID (HD-5-FU/FA) IN CYTOSTATIC NAIVE OR PRETREATED ADVANCED COLORECTAL-CANCER - REMISSION RATES AND SURVIVAL/, Annals of oncology, 9, 1998, pp. 197-197
IMPACT OF CLINICAL AND MORPHOLOGICAL VARIABLES IN CLASSIFICATION AND REGRESSION TREE-BASED SURVIVAL (CART) ANALYSIS OF CML WITH SPECIAL EMPHASIS ON DYNAMIC FEATURES
Authors: THIELE J KVASNICKA HM ZIRBES TK FLUCKE U NIEDERLE N LEDER LD DIEHL V FISCHER R
Citation: J. Thiele et al., IMPACT OF CLINICAL AND MORPHOLOGICAL VARIABLES IN CLASSIFICATION AND REGRESSION TREE-BASED SURVIVAL (CART) ANALYSIS OF CML WITH SPECIAL EMPHASIS ON DYNAMIC FEATURES, European journal of haematology, 60(1), 1998, pp. 35-46
TREOSULFAN AS REINDUCTION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
Authors: STEFFENS F HEIDER A NIEDERLE N
Citation: F. Steffens et al., TREOSULFAN AS REINDUCTION CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER, Onkologie, 21(4), 1998, pp. 320-322
RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER
Authors: ROUGIER P VANCUTSEM E BAJETTA E NIEDERLE N POSSINGER K LABIANCA R NAVARRO M MORANT R BLEIBERG H WILS J AWAD L HERAIT P JACQUES C
Citation: P. Rougier et al., RANDOMIZED TRIAL OF IRINOTECAN VERSUS FLUOROURACIL BY CONTINUOUS-INFUSION AFTER FLUOROURACIL FAILURE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Lancet, 352(9138), 1998, pp. 1407-1412
BENDAMUSTIN - RELAPSE THERAPY IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL)
Authors: HEIDER A STEFFENS F KOCH J NIEDERLE N
Citation: A. Heider et al., BENDAMUSTIN - RELAPSE THERAPY IN PATIENTS WITH LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), European journal of cancer, 33, 1997, pp. 1219-1219
HYPERSENSITIVITY REACTIONS TO PARENTERAL LIPID SOLUTIONS
Authors: WEIDMANN B LEPIQUE C HEIDER A SCHMITZ A NIEDERLE N
Citation: B. Weidmann et al., HYPERSENSITIVITY REACTIONS TO PARENTERAL LIPID SOLUTIONS, Supportive care in cancer, 5(6), 1997, pp. 504-505
BENDAMUSTIN AS 2ND-LINE THERAPY IN PATIEN TS WITH RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA
Authors: HEIDER A KRESS M NIEDERLE N
Citation: A. Heider et al., BENDAMUSTIN AS 2ND-LINE THERAPY IN PATIEN TS WITH RELAPSED LOW-GRADE NON-HODGKINS-LYMPHOMA AND MULTIPLE-MYELOMA, Tumordiagnostik & Therapie, 18(3), 1997, pp. 71-75
FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) REVEALS THAT IN CHRONIC MYELOGENOUS LEUKEMIA (CML) FOLLOWING INTERFERON-ALPHA THERAPY, NORMALIZATION OF MEGAKARYOCYTE SIZE IS ASSOCIATED WITH THE LOSS OF BCR ABL TRANSLOCATION/
Authors: THIELE J SCHMITZ B GROSS H KVASNICKA HM NIEDERLE N LEDER LD FISCHER R
Citation: J. Thiele et al., FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) REVEALS THAT IN CHRONIC MYELOGENOUS LEUKEMIA (CML) FOLLOWING INTERFERON-ALPHA THERAPY, NORMALIZATION OF MEGAKARYOCYTE SIZE IS ASSOCIATED WITH THE LOSS OF BCR ABL TRANSLOCATION/, Histopathology, 31(3), 1997, pp. 215-221
APOPTOSIS AND PROLIFERATION (PCNA LABELING) IN CML - A COMPARATIVE IMMUNOHISTOLOGICAL STUDY ON BONE-MARROW BIOPSIES FOLLOWING INTERFERON AND BUSULFAN THERAPY
Authors: THIELE J ZIRBES TK LORENZEN J KVASNICKA HM DRESBACH S MANICH B LEDER LD NIEDERLE N DIEHL V FISCHER R
Citation: J. Thiele et al., APOPTOSIS AND PROLIFERATION (PCNA LABELING) IN CML - A COMPARATIVE IMMUNOHISTOLOGICAL STUDY ON BONE-MARROW BIOPSIES FOLLOWING INTERFERON AND BUSULFAN THERAPY, Journal of pathology, 181(3), 1997, pp. 316-322
UPPER GASTROINTESTINAL-BLEEDING AS INITIA L MANIFESTATION OF A NONSEMINOMATOUS TESTICULAR-CARCINOMA
Authors: WEIDMANN B EISENBACH T BORGER R NIEDERLE N
Citation: B. Weidmann et al., UPPER GASTROINTESTINAL-BLEEDING AS INITIA L MANIFESTATION OF A NONSEMINOMATOUS TESTICULAR-CARCINOMA, Deutsche Medizinische Wochenschrift, 121(46), 1996, pp. 1428-1432
EFFECTS OF INTERFERON TREATMENT ON THE MACROPHAGE POPULATION IN THE BONE-MARROW OF PATIENTS WITH PH(1-CML())
Authors: THIELE J KVASNICKA HM ZIRBES TK BALDUS SE DJUREN O LIENHARD H LORENZEN J LEDER LD NIEDERLE N FISCHER R
Citation: J. Thiele et al., EFFECTS OF INTERFERON TREATMENT ON THE MACROPHAGE POPULATION IN THE BONE-MARROW OF PATIENTS WITH PH(1-CML()), Hematopathology and molecular hematology, 10(4), 1996, pp. 201-212
EFFECT OF INTERFERON THERAPY ON BONE-MARROW MORPHOLOGY IN CHRONIC MYELOID-LEUKEMIA - A CYTOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDY OF TREPHINE BIOPSIES
Authors: THIELE J ZIRBES TK KVASNICKA HM LORENZEN J NIEDERLE N LEDER LD FISCHER R
Citation: J. Thiele et al., EFFECT OF INTERFERON THERAPY ON BONE-MARROW MORPHOLOGY IN CHRONIC MYELOID-LEUKEMIA - A CYTOCHEMICAL AND IMMUNOHISTOCHEMICAL STUDY OF TREPHINE BIOPSIES, Journal of interferon & cytokine research, 16(3), 1996, pp. 217-224
INTERFERON THERAPY, BUT NOT BUSULFAN RESTORES NORMAL-SIZED MEGAKARYOPOIESIS IN CML - A COMPARATIVE HISTOMORPHOMETRIC AND IMMUNOMORPHOMETRICSTUDY
Authors: THIELE J ZIRBES T KVASNICKA HM NIEDERLE N DAMMASCH J SCHMIDT M WINDECKER R LEDER LD DIEHL V FISCHER R
Citation: J. Thiele et al., INTERFERON THERAPY, BUT NOT BUSULFAN RESTORES NORMAL-SIZED MEGAKARYOPOIESIS IN CML - A COMPARATIVE HISTOMORPHOMETRIC AND IMMUNOMORPHOMETRICSTUDY, Analytical cellular pathology, 11(1), 1996, pp. 31-42
PROGNOSTIC IMPACT OF INTERFERON ALPHA-INDUCED CYTOGENETIC REMISSION IN CHRONIC MYELOGENOUS LEUKEMIA - LONG-TERM FOLLOW-UP
Authors: KLOKE O NIEDERLE N OPALKA B HAWIG I SEEBER S BECHER R
Citation: O. Kloke et al., PROGNOSTIC IMPACT OF INTERFERON ALPHA-INDUCED CYTOGENETIC REMISSION IN CHRONIC MYELOGENOUS LEUKEMIA - LONG-TERM FOLLOW-UP, European journal of haematology, 56(1-2), 1996, pp. 78-81
IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCI ES
Authors: WINKLER U BOHLEN H SCHIRRMACHER V SCHLIMOK G VOLIOTIS D BRACH M NIEDERLE N TECH H DIEHL V ENGERT A
Citation: U. Winkler et al., IMMUNOTHERAPY OF HEMATOLOGICAL MALIGNANCI ES, Medizinische Klinik, 91(4), 1996, pp. 226-233
MENINGEAL CARCINOMATOSIS ASSOCIATED WITH BREAST-CANCER
Authors: RAFFELSIEPER B NIEDERLE N ASSHEUER J MENNEL HD BEWERMEYER H
Citation: B. Raffelsieper et al., MENINGEAL CARCINOMATOSIS ASSOCIATED WITH BREAST-CANCER, Tumordiagnostik & Therapie, 17(6), 1996, pp. 191-195
PHASE-II STUDY OF PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER
Authors: VONPAWEL J WAGNER H NIEDERLE N HEIDER A KOSCHEL G HECKER D HANSKE M
Citation: J. Vonpawel et al., PHASE-II STUDY OF PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER, Seminars in oncology, 23(6), 1996, pp. 47-50
PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER -RESULTS OF A PHASE-II TRIAL
Authors: VONPAWEL J WAGNER H NIEDERLE N HEIDER A KOSCHEL G GROMOTKA E HANSKE M
Citation: J. Vonpawel et al., PACLITAXEL AND CISPLATIN IN PATIENTS WITH NONSMALL CELL LUNG-CANCER -RESULTS OF A PHASE-II TRIAL, Seminars in oncology, 23(5), 1996, pp. 7-9
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
Authors: ALBERTI W ANDERSON G BARTOLUCCI A BELL D VILLALBA JB BRODIN O CARDIELLO C CARTEI F CARTEI G CELLERINO R CHASTANG C CORMIER Y COX JD CRINO L CROWLEY J DAUTZENBERG B DEPIERRE A DIETEMANN A DILLMAN RO DOI O FELD R FIGLIN R GANZ PA GREEN MR GREGOR A HELLE PA HERNDON JE HITOMI S HOST H IMAIZUMI M JETT JR JOHNSON D KAASA S KIMURA H KLASTERSKY J KONDO H KREISMAN H KRIS MG KUNISHIMA K KUWAHARA O LAD TE LAING AH MACBETH F MASAOKA A MATTSON K MINATEL E MIRA JG MORI T MOUNTAIN CF NIEDERLE N NIIRANEN A NOU E PAGE W PATER J PIANTADOSI S PISTERS KMW PYRHONEN S QUOIX E RAPP E ROWELL NP SAHMOUD T SAWAMURA K SCHALLIER DCC SCOTT C SIMPSON J STAGG M TERAMATSU T TROVO MG TSUCHIYA R TUMMARELLO D VANHOUTTE P VANZANDWIJK N VINCENT RG WADA H WHITE JE WILLIAMS CJ WOODS RL YAMAGUCHI Y ARRIAGADA R CARTMELLDAVIES J GIRLING DJ LECHEVALIER T MARSONI S PARMAR MKB PIGNON JP REKACEWICZ C SOUHAMI RL STEWART LA TARAYRE M TINAZZI A TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
PATTERN OF CARBOPLATIN-INDUCED EMESIS
Authors: DUBOIS A VACH W CRAMERGIRAUD U THOMSSEN C GLAUBITZ M FIOLA M AUGENER W BARTSCH W BERGMANN F BIERBAUM W KRAPP J BONING L BONGARTZ U BRUNTSCH U VONBULTZINGSLOWEN F DIETL J FUGER T FULLE HH GATZEMEIER U GROPP C HARTLAPP H HERSCHLEIN HJ HOLTKAMP W HURST U JANICKE F KAUKEL E KLEEBERG U ENGEL E KRAFFT W KUHNLE H LINDEMANN H MARSCHNER N MEERPOHL HG NIEDERLE N OSIEKA R PLANKER M RIESS H SCHMIDT M SCHMOLL HJ SCHUNEMANN H WEINGARTJESSE B WEITZEL H WESTERHAUSEN M WINKELMANN M
Citation: A. Dubois et al., PATTERN OF CARBOPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6(5), 1995, pp. 645-651
THE IMPACT OF INTERFERON VERSUS BUSULFAN THERAPY ON THE RETICULIN STAIN-MEASURED FIBROSIS IN CML - A COMPARATIVE MORPHOMETRIC STUDY ON SEQUENTIAL TREPHINE BIOPSIES
Authors: THIELE J KVASNICKA HM NIEDERLE N ZIRBES TK SCHMIDT M DAMMASCH J MEUTER BR LEDER LD KLOKE O DIEHL V FISCHER R
Citation: J. Thiele et al., THE IMPACT OF INTERFERON VERSUS BUSULFAN THERAPY ON THE RETICULIN STAIN-MEASURED FIBROSIS IN CML - A COMPARATIVE MORPHOMETRIC STUDY ON SEQUENTIAL TREPHINE BIOPSIES, Annals of hematology, 70(3), 1995, pp. 121-128
PRIMARY LEPTOMENINGEAL AMELANOTIC MELANOB LASTOMA
Authors: NELLES G MENNEL HD NIEDERLE N HOJER C BEWERMEYER H
Citation: G. Nelles et al., PRIMARY LEPTOMENINGEAL AMELANOTIC MELANOB LASTOMA, Tumordiagnostik & Therapie, 16(1), 1995, pp. 32-36
CLINICAL AND HISTOLOGICAL FEATURES RETAIN THEIR PROGNOSTIC IMPACT UNDER INTERFERON THERAPY OF CML - A PILOT-STUDY
Authors: THIELE J KVASNICKA HM NIEDERLE N KLOKE O SCHMIDT M LIENHARD H ZIRBES T MEUTER RB LEDER LD FISCHER R
Citation: J. Thiele et al., CLINICAL AND HISTOLOGICAL FEATURES RETAIN THEIR PROGNOSTIC IMPACT UNDER INTERFERON THERAPY OF CML - A PILOT-STUDY, American journal of hematology, 50(1), 1995, pp. 30-39
DOUBLE HIGH-DOSE CHEMOTHERAPY (HDCT) WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER AND HIGH-GRADE LYMPHOMA
Authors: BOJKO P KLOSTER G WEIDMANN B GACZKOWSKI A HALBE J NIEDERLE N
Citation: P. Bojko et al., DOUBLE HIGH-DOSE CHEMOTHERAPY (HDCT) WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER AND HIGH-GRADE LYMPHOMA, Blood, 86(10), 1995, pp. 3739-3739
PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME
Authors: BEELEN DW GRAEVEN U ELMAAGACLI AH NIEDERLE N KLOKE O OPALKA B SCHAEFER UW
Citation: Dw. Beelen et al., PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME, Blood, 85(10), 1995, pp. 2981-2990
Risultati: 1-25 | 26-34